Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 11Unknown 3Terminated 3Withdrawn 2

Sponsor Class

NIH 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 2Genitourinary 1

Conditions

Lymphoma 2Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × keyhole-limpet hemocyanin × Clear all
NCT00093522 2013-12-19

Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
28 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00017290 2013-12-04

Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Unknown
Lymphoid

Lymphoma, Lymphoma, Follicular

NCT00091676 2012-02-03

BiovaxID

Biovest International

Phase 3 Unknown
629 enrolled
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡